Keion Crossen

Cornerback

Age: 27
Free Agency: 2025 (UFA)
Accrued Seasons: 5
  • 2023 Salary Cap Charge: $3,155,000 (1.40% of cap)
  • 2023 Cash Payout: $3,170,000 (1.15% of spending)
  • 2023 Cash to Cap Ratio: 1.00
  • Contract Value: $9,450,000 ($3,150,000 APY)
  • Fully Guaranteed Money: $3,035,000
  • Contract Ranking: 59/345 at CB

Current Contract

(UFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202226$1,035,000$2,000,000$0$0$3,035,000$3,035,0001.4%
202327$2,865,000$0$255,000$50,000$0$3,155,0001.4%
202428$2,940,000$0$255,000$50,000$0$3,245,0001.3%
Total$6,840,000$2,000,000$510,000$100,000$3,035,000$9,435,000

Contract Notes

Keion Crossen signed a three year contract with the Dolphins on March 15, 2022. Contract value is $9.45 million with $3.035 million virtually guaranteed. Crossen has a fully guaranteed salary in 2022 and a roster bonus of $2 million due March 22, 2022. An additional $1.05 million are available through incentives.

Cash Flows

- fully earned money
- unearned or partially earned money
$3.2M
$6.3M
$9.5M
202220232024
Cash Due$3,035,000$3,170,000$3,245,000
Running Cash$3,035,000$6,205,000$9,450,000
Career Earnings: $5,829,392
Career APY: $1,165,878
Potential Earnings: $12,244,392
Total Guarantees: $3,258,176
Largest Cash Payment: $3,245,000 (2024)
Largest Cap Number: $3,245,000 (2024)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
GiantsDraftedExpired20184$2,534,392$633,598$74,392$920,00036.3%$920,000
PatriotsDraftedTraded20184$2,534,392$633,598$74,392$554,39221.9%$554,392
TexansDraftedTraded20184$2,534,392$633,598$74,392$1,320,00052.1%$660,000
DolphinsUFAActive20223$9,450,000$3,150,000$3,035,000$3,035,00032.1%$3,035,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Giants1$920,000$920,000$920,0000.0%$00.0%
Patriots1$554,392$554,392$498,5980.0%$55,7940.0%
Texans2$1,320,000$660,000$1,320,0000.0%$00.0%
Dolphins1$3,035,000$3,035,000$3,035,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Patriots$480,000$18,598$0$0$0$0$498,5980.3%$554,392
2019Texans$570,000$0$0$0$0$0$570,0000.3%$570,000
2020Texans$750,000$0$0$0$0$0$750,0000.3%$750,000
2021Giants$920,000$0$0$0$0$0$920,0000.5%$920,000
2022Dolphins$1,035,000$0$2,000,000$0$0$3,035,000$3,035,0001.4%$3,035,000
2023Dolphins$2,865,000$0$0$255,000$50,000$0$3,155,0001.4%$3,170,000
2024Dolphins$2,940,000$0$0$255,000$50,000$0$3,245,0001.3%$3,245,000
Total$9,560,000$18,598$2,000,000$510,000$100,000$3,035,000$12,173,598$12,244,392
Dead Money History
TeamYearCap ChargeCash Paid
Patriots2019$18,598$0
Patriots2020$37,196$0
Total$55,794$0

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201811143.7%24.9%0000000000000
2019160012.3%58.8%10300011000000
2020160027.7%59.0%25900005000000
202116002.0%70.4%1118110000000
2022160133.5%47.0%16900004000000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,097,000$3,150,000
Injury Adjusted$1,097,000$3,150,000
test
OTC Valuation $3.5M $7M $10.5M $14M $17.5M APY $3.5M $7M $10.5M $14M $17.5M $4,552,000 $4,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.